Stephanie Gray

Stephanie Gray supports the Naval Medical Research Center’s mission by managing strategic acquisitions in biomedical research and diagnostic innovation, ensuring the U.S. Navy and Marine Corps have access to advanced, field-deployable medical technologies. She oversees procurement activities aligned with force health protection priorities, focusing on analytical laboratory instruments and applied research services that enable rapid pathogen detection and precision monitoring in austere environments. Her role is central to translating operational needs into technically sound contracts that accelerate the transition of laboratory discoveries into deployable capabilities. Gray maintains a strong, recurring partnership with REES SCIENTIFIC CORPORATION, a key vendor specializing in high-precision analytical instrumentation and custom diagnostic system development. Her contracting patterns reflect a preference for established technical partners with proven expertise in laboratory-grade equipment and research support services, indicating a reliance on vendors capable of meeting stringent military specifications for reliability and field performance. These relationships are characterized by repeat engagements and technical collaboration rather than transactional procurement. Gray’s procurement portfolio reflects no set-aside preferences, with 100% of awards issued under full and open competition. This indicates a focus on technical capability and mission-critical performance over socioeconomic targeting, aligning with the Center’s urgent need for specialized, high-performance solutions that may not be readily available from small business pools in this niche domain. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 541712 (Research and Development in the Physical, Engineering, and Life Sciences), reflecting deep expertise in acquiring mass spectrometers, PCR-based diagnostic platforms, biosensors, and custom R&D services for infectious disease surveillance. She consistently sources mission-critical technologies that bridge laboratory innovation with operational readiness, supporting the Center’s leadership in defense biomedical science.